A detailed history of Fundamentun, LLC transactions in Amgen Inc stock. As of the latest transaction made, Fundamentun, LLC holds 18,352 shares of AMGN stock, worth $4.82 Million. This represents 0.44% of its overall portfolio holdings.

Number of Shares
18,352
Previous 17,607 4.23%
Holding current value
$4.82 Million
Previous $5.5 Million 7.49%
% of portfolio
0.44%
Previous 0.49%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 17, 2024

BUY
$309.38 - $337.38 $230,488 - $251,348
745 Added 4.23%
18,352 $5.91 Million
Q2 2024

Jul 24, 2024

SELL
$262.75 - $319.31 $1.78 Million - $2.16 Million
-6,774 Reduced 27.78%
17,607 $5.5 Million
Q1 2024

Apr 16, 2024

BUY
$268.87 - $324.56 $56,462 - $68,157
210 Added 0.87%
24,381 $6.93 Million
Q4 2023

Jan 24, 2024

BUY
$255.7 - $288.46 $499,637 - $563,650
1,954 Added 8.8%
24,171 $6.96 Million
Q3 2023

Oct 24, 2023

BUY
$218.65 - $271.46 $382,637 - $475,054
1,750 Added 8.55%
22,217 $5.97 Million
Q2 2023

Jul 18, 2023

BUY
$214.27 - $253.37 $60,424 - $71,450
282 Added 1.4%
20,467 $4.54 Million
Q1 2023

May 01, 2023

BUY
$225.79 - $275.2 $296,010 - $360,787
1,311 Added 6.95%
20,185 $4.88 Million
Q4 2022

Jan 19, 2023

BUY
$229.03 - $291.01 $59,776 - $75,953
261 Added 1.4%
18,874 $0
Q3 2022

Oct 24, 2022

SELL
$224.46 - $253.15 $152,857 - $172,395
-681 Reduced 3.53%
18,613 $4.2 Million
Q2 2022

Sep 06, 2022

BUY
$230.71 - $256.74 $54,216 - $60,333
235 Added 1.23%
19,294 $4.69 Million
Q1 2022

Apr 26, 2022

BUY
$219.27 - $242.57 $84,638 - $93,632
386 Added 2.07%
19,059 $4.61 Million
Q4 2021

Jan 14, 2022

BUY
$198.88 - $227.6 $299,513 - $342,765
1,506 Added 8.77%
18,673 $4.2 Million
Q3 2021

Oct 19, 2021

BUY
$212.27 - $248.7 $697,731 - $817,476
3,287 Added 23.68%
17,167 $3.65 Million
Q2 2021

Jul 19, 2021

BUY
$233.58 - $259.14 $231,944 - $257,326
993 Added 7.71%
13,880 $3.38 Million
Q1 2021

Apr 27, 2021

SELL
$221.91 - $258.6 $99,859 - $116,370
-450 Reduced 3.37%
12,887 $3.21 Million
Q4 2020

Jan 29, 2021

BUY
$216.38 - $257.67 $645,028 - $768,114
2,981 Added 28.79%
13,337 $3.07 Million
Q3 2020

Oct 29, 2020

BUY
$234.65 - $260.95 $80,484 - $89,505
343 Added 3.43%
10,356 $2.63 Million
Q2 2020

Jul 28, 2020

BUY
$197.81 - $242.74 $263,087 - $322,844
1,330 Added 15.32%
10,013 $2.36 Million
Q1 2020

May 04, 2020

BUY
$182.24 - $241.7 $1.17 Million - $1.55 Million
6,396 Added 279.67%
8,683 $1.76 Million
Q4 2019

Jan 29, 2020

BUY
$189.21 - $243.2 $432,723 - $556,198
2,287 New
2,287 $551,000

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $140B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Fundamentun, LLC Portfolio

Follow Fundamentun, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fundamentun, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fundamentun, LLC with notifications on news.